Lung cancer - UK incidence statistics

This page presents lung cancer incidence statistics by age and sex, histology, geographic variation, trends over time, trends by age, ethnicity, deprivation and prevalence.The ICD code for lung cancer is ICD-10 C33-34.

 

By age and sex

Lung cancer is the most common cancer in the world with 1.61 million new cases diagnosed every year1. The vast majority of lung cancers are caused by cigarette smoking. It has been estimated that the lifetime risk of developing lung cancer in 2008 is 1 in 14 for men and 1 in 19 for women in the UK.This was done using the AMP method22.

Until the late 1990s, lung cancer was the most frequently occurring cancer in the UK; in 1997 it was overtaken by breast cancer, but still accounts for around 1 in 8 new cancer cases, that is, 40,806 new cases diagnosed in 2008 (Table 1.1). 2-5

Table 1.1: Lung Cancer (C33-34), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2008

England Wales Scotland Northern Ireland United Kingdom
Male Cases 18,399 1,346 2,477 624 22,846
Crude Rate 72.7 92.2 99.1 71.7 75.8
AS Rate 57.1 64.4 77.6 65.8 59.4
AS Rate - 95% LCL* 56.2 60.9 74.6 60.6 58.7
AS Rate - 95% UCL* 57.9 67.8 80.7 70.9 60.2
Female Cases 14,147 1,057 2,373 383 17,960
Crude Rate 54.1 69.0 88.9 42.4 57.5
AS Rate 36.6 42.5 58.1 33.7 38.8
AS Rate - 95% LCL* 36.0 40.0 55.8 30.4 38.2
AS Rate - 95% UCL* 37.2 45.1 60.5 37.1 39.3
Persons Cases 32,546 2,403 4,850 1,007 40,806
Crude Rate 63.2 80.4 93.8 56.7 66.5
AS Rate 45.6 52.2 66.4 47.5 47.8
AS Rate - 95% LCL* 45.1 50.1 64.5 44.6 47.3
AS Rate - 95% UCL* 46.0 54.2 68.2 50.4 48.2

Download this table (42KB)

*95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS rate

While there are more cases of lung cancer diagnosed in men, the numbers of women being diagnosed has increased. Lung cancer incidence and mortality rates were among the highest in the world but smoking cessation has lead to record falls, particularly among men.

Lung cancer is rarely diagnosed in people younger than 40, but incidence rises steeply thereafter peaking in people aged 80-84 years (Figure 1.1). 2-5 Most cases (87%) occur in people over the age of 60.

In the 1950s the male/female ratio for lung cancer cases was 6:1 but with decreasing male rates and increasing female rates, the ratio is now 1.3:1. Overall, 13% of all new cases of cancer are lung cancers.

Figure 1.1: Lung Cancer (C33-34), Average Number of New Cases per Year and Age-Specific Incidence Rates, UK, 2006-2008

cases_crude_lung1.swf

Download this chart (66KB)

In men, lung cancer is the second most common cancer after prostate cancer, responsible for 15% of all new male cancer cases. For women, it is the second most common cancer after breast cancer, accounting for 12% of all new female cases.

section updated 17/08/11

 

Histology

There are two main types of lung cancers: around 20% are small cell lung cancers (SCLC) and the remainder are non-small cell lung cancers (NSCLC).

The main types of NSCLC are squamous cell carcinoma, adenocarcinoma and large cell carcinoma, which account for approximately 35%, 27% and 10% of all lung cancer cases, respectively, in the UK 6.

While cigarette smoking has been linked to all four types of lung cancer, adenocarcinoma is the most common type in non-smokers 18 and a rise in incidence has been reported in the USA and other countries 7-9.

In the USA, adenocarcinoma is now the most common type of lung cancer. In Europe the most common type of lung cancer is still squamous cell carcinoma despite increases in the incidence of adenocarcinoma 9. The increasing incidence of adenocarcinoma has been linked to low-tar cigarettes10.

section updated 09/03/11

 

 

Across the UK and worldwide

The poor prognosis for lung cancer means that incidence and mortality patterns are very similar in all parts of the world.

Within the UK, there is a clear north/south divide with high lung cancer incidence rates in Scotland and northern England, and generally lower incidence in Wales, the Midlands and southern England 19. Scottish men and women have amongst the highest rates in the world reflecting the country’s history of high smoking prevalence 11, 12.

Lung cancer incidence rates in Scotland are particularly high in the densely populated belt from Glasgow in the west to Edinburgh in the east 19. The higher rates in urban rather than rural areas are mainly the result of higher smoking prevalence in urban areas. 20.

Other factors such as poor diet, exposure to industrial carcinogens and air pollution may also contribute 13, 20. In the West of Scotland, about 6% of male lung cancers are attributed to asbestos exposure associated with the ship-building industry 14.

Lung cancer incidence rates vary hugely between different regions of the world. The highest rates of lung cancer in men are found in Europe, especially central and eastern Europe, and northern America. Within the European Union (EU-27) the countries with the highest male rates are Hungary and Poland and the lowest in Sweden and Cyprus (Figure 1.2) 1

Figure 1.2: Lung cancer (C33-34), European Age-Standardised Incidence Rates, EU-27 Countries, 2008 Estimates

EU27_inc_lung.swf

Download this chart (67KB)

For women the highest rates of lung cancer are found in northern America and northern Europe. 

The lowest lung cancer incidence rates in both men and women are found in African countries. Further information on geographical variation in lung cancer incidence rates can be found in the mortality section.

section updated 18/07/11

 

Trends over time

UK incidence trends follow the same pattern as the mortality trends which are described in the mortality section. Figure 1.3 shows the incidence trend for the UK.

Figure 1.3: Lung Cancer (C33-34), European Age-Standardised Incidence Rates, UK, 1993-2008

inc_asr_uk_lung.swf

Download this chart (56KB)

Between 1993 and 2008 male lung cancer incidence rates decreased by almost a third (32%). Over the same period there was an increase in the female rates (11%). For males and females combined, the lung cancer incidence rate decreased by 15%.

Longer trends in lung cancer incidence in Great Britain are shown in Figure 1.4. Male lung cancer rates for males have fallen by 47% from 113 per 100,000 in 1975 to 59 in 2008. Over the same time period female lung cancer incidence rates have risen by 71% from 23 to 39 per 100,000 population.

Figure 1.4: Lung Cancer (C33-34), European Age-Standardised Incidence Rates, Great Britain, 1975-2008

inc_asr_gb_lung.swf

Download this chart (59KB)

   section updated 29/06/11

 

Deprivation

Lung cancer incidence and mortality rates are strongly associated with deprivation.

In an analysis of 1993 lung cancer incidence data for England & Wales by Carstairs deprivation index, incidence was almost 2.5 times higher in the most deprived male groups compared to the least deprived - the difference for women was even greater at 3 times ( Figure 1.5).17

Chart showing age-standardised lung cancer incidence rates by deprivation category in England and Wales

A similar association with deprivation is evident in Scotland where rates for people diagnosed with lung cancer between 1991 and 1995 were twice as high in the most deprived group compared to the least deprived 3.

More recent data from the West Midlands records that between 1981 and 2004 lung cancer age-standardised incidence rates for the most affluent men remained relatively stable at around 56 per 100,000, while in the most deprived male group, they dropped by 56% from 186.4 per 100,000 to 81.5 per 100,000 over the period 21.

The latest analysis of lung cancer incidence by deprivation in England showed that incidence was almost 2.5 times higher in the most deprived groups compared to the least deprived (75.2 compared to 29.8 per 100,000 population).

The difference was greater for women than for men. The lung cancer incidence rate for men in the most deprived group was 2.4 times higher than the least deprived (100.6 compared to 41.3), whereas for women it was almost 2.7 times higher (55.9 compared to 20.9). 22.

section updated 09/03/11

 

Trends over time by age

In Great Britain, all age groups in men have shown a reduction in lung cancer rates since the mid 1970's. In the over 60 year olds rates fell from 529 cases per 100,000 in 1975 to 309 cases per 100,000 in 2008. Rates in men over 80 rose considerably between 1975 to 1985, going from 530 cases per 100,000 to 825 per 100,000. Since then the rates have fallen steadily to around 560 cases per 100,000 in 2008 but they remain above the level of 1975 (Figure 1.6)2-5

Figure 1.6: Lung cancer (C33-34), European Age-Standardised Incidence Rates, Males, by Age, Great Britain, 1975-2008

age_male_gb_lung

Download this chart (73KB)

Since the mid 1970’s rates for women over 60 with lung cancer, doubled from 93 per 100,000 to 189 per 100,000 in 2008 in Great Britain.

Rates in the 70-79 year olds had risen up to the end of the last millennium, but have been stable since then.

Women over 80 had the greatest increase of all, with lung cancer rates more than tripling from 84 per 100,000 in 1975 to 273 cases per 100,000 women in 2008. These rates have consistently risen by an alarming amount. 

Since the late 1980s there was some improvement for women aged 60-69, with lung cancer rates levelling out and then falling. But, worryingly, since 2002 these rates have steadily gone back up.

Only the 40-49 year old females have shown a reduction in rates, falling by around a fifth, from 14 per 100,000 in 1975 to 11 per 100,000 in 2008 (Figure 1.7)2-5

Figure 1.7: Lung cancer (C33-34), European Age-Standardised Incidence Rates, Females, by Age, Great Britain, 1975-2008

age_fem_gb_lung

Download this chart (70KB)

section updated 09/03/11

 

 

Ethnicity

Within the UK, south Asians have a lower incidence of lung cancer than non-south Asians. However, increasing incidence has been reported amongst south Asian men in contrast to the rest of the UK male population.

South Asian women also have increasing lung cancer trends but this is in line with the rest of the UK female population 15.

In the USA lung cancer rates in the black population are higher for both males and females compared to the white population. Other ethnic groups such as Hispanics and Asians have lower rates than whites 16.

 

Prevalence

Prevalence data relate to those people in the UK population who were alive on a specific date having previously been diagnosed with cancer. Relatively low survival rates for lung cancer mean that despite high incidence rates there are fewer patients alive who have been diagnosed with lung cancer relative to the other major cancers. 

The latest analysis shows that on 31st December 2006, just over 38,000 people were alive up to ten years after being diagnosed with lung cancer23. Table 1.2 shows the one, five and ten year prevalence by sex for lung cancer.

table showing lung cancer prevalence in the UK

General information about cancer prevalence in the UK can be found in the Prevalence section of the CancerStats website.

section updated 22/06/11

icon-a-z-20x20

Visit our A-Z topic pages

References for lung cancer incidence

  1.  European age-standardised rates calculated by the Statistical Information Team at Cancer Research UK, 2011 using data from GLOBOCAN 2008 v1.2, IARC, http://globocan.iarc.fr
  2.  Office for National Statistics, Cancer Statistics registrations: registrations of cancer diagnosed in 2008, England. (PFD 544KB) MB1 Series 39, 2010 2010
  3.  ISD Online. Cancer Incidence, Mortality and Survival data. Accessed 2010
  4.  Welsh Cancer Intelligence and Surveillance Unit, Cancer Incidence in Wales.2010
  5.  Northern Ireland Cancer Registry. Cancer Incidence and Mortality. Accessed 2010
  6.  National Institute for Clinical Excellence. Lung Cancer. The diagnosis and treatment of lung cancer; 2005
  7.  Doll R, Fraumeni Jr J, Muir CS.Trends in Cancer Incidence and Mortality. In: Sidebottom E, ed. Cancer Surveys.Vol. 19/20. New York: Cold Spring Harbor Laboratory Press, 1994.
  8.  Janssen-Heijnen, M.L. and J.W. Coebergh, The changing epidemiology of lung cancer in Europe. Lung Cancer, 2003. 41(3): p. 245-58
  9.  Harkness, E.F., et al., Changing trends in incidence of lung cancer by histologic type in Scotland. Int J Cancer, 2002. 102(2): p. 179-83
  10.  Franceschi, S. and E. Bidoli, The epidemiology of lung cancer. Ann Oncol, 1999. 10 Suppl 5: p. S3-6
  11.  Harris V, Sandridge A, Black R, Brewster D, Gould A. Cancer Registration Statistics: Scotland 1986-1995. Edinburgh: ISD Scotland Publications, 1998.
  12.  Parkin DM, Whelan SL, Ferlay J,Teppo L,Thomas DB. Cancer Incidence in Five Continents Volume VIII. IARC Scientific Publications.Vol. 155. Lyon, France: International Agency for Research on Cancer, 2002.
  13.  Scottish Executive Health Department. Cancer Scenarios: An aid to planning cancer services in Scotland in the next decade. Edinburgh:The Scottish Executive, 2001.
  14.  De Vos Irvine, H., et al., Asbestos and lung cancer in Glasgow and the west of Scotland. Bmj, 1993. 306(6891): p. 1503-6
  15.  Smith, L.K., M.D. Peake, and J.L. Botha, Recent changes in lung cancer incidence for south Asians: a population based register study. Bmj, 2003. 326(7380): p. 81-2
  16.  Ries LA, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000.National Cancer Institute, 2003. Bethesda, MD
  17.  Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer Trends in England & Wales 1950-1999. (PDF 5897KB) SMPS No. 66: TSO, 2001
  18.  Subramanian J, Govindan R, Lung cancer in never smokers J Clin Oncol 2007; 25 (5):561-70
  19.  Quinn M, Cooper N, Rowan S Cancer Atlas of the United Kingdom and Ireland 1991-2000 (PDF 785KB)Office for National Statistics, 2005
  20.  Pearce J, Boyle P Is the urban excess in lung cancer in Scotland explained by patterns of smoking? Soc Sci Med 2005;60(12):2833-43
  21.  West Midlands Cancer Intelligence Unit Lung cancer in the West Midlands 2006
  22.  Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB  What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries. Br J Cancer, 2011. 105(3): p. 460-5.
  23.  National Cancer Intelligence Network (NCIN) One, Five and Ten Year Cancer Prevalence June 2010